Patent details

Basic Information

Publication number:

EP2471519

PCT Application Number:

CN2010077466

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP108199126

PCT Publication Number:

WO2011038683

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

CONTROLLED RELEASE FORMULATION OF CARVEDILOL

French Title of Invention:

FORMULATION DE CARVEDILOL À LIBÉRATION CONTRÔLÉE

German Title of Invention:

FORMULIERUNG AUS CARVEDILOL MIT GESTEUERTER FREISETZUNG

SPC Number:

Dates

Filing date:

29/09/2010

Grant date:

26/08/2020

EP Publication Date:

04/07/2012

PCT Publication Date:

07/04/2011

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

26/08/2020

EP B1 Publication Date:

26/08/2020

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

29/09/2020

Expiration date:

29/09/2030

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

19/08/2020

 

 

Name:

Shandong New Time Pharmaceutical Co., LTD.

Address:

No. 1, North Outer Ring Road, Feixian County Shandong Province, China (CN)

Inventor

1

Name:

LIN, Tsung-Hsin

Address:

China (CN)

2

Name:

LU, Ta-Chien

Address:

China (CN)

3

Name:

HAO, Wei-Hua

Address:

China (CN)

Priority

Priority Number:

246804 P

Priority Date:

29/09/2009

Priority Country:

United States (US)

Classification

IPC classification:

A61K 9/20; A61K 9/24; A61K 31/403; A61P 9/00;

Publication

European Patent Bulletin

Issue number:

202035

Publication date:

26/08/2020

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages